AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2008
Aug 8, 2008
30718_dirs_2008-08-08_a205c1f0-e47b-434e-ac50-c8d1602ff27f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (Tech)
CIK: 0000842023
Period of Report: 2008-08-07
Reporting Person: OCONNELL HOWARD V (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-08-07 | Common Stock | M | 5000 | $29.1 | Acquired | 5000 | Direct |
| 2008-08-07 | Common Stock | S | 5000 | $80.21 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-08-07 | Director Stock Option | $29.1 | M | 2000 | Disposed | 2011-10-18 | Common Stock (2000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 135389 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option | $52.6565 | 2010-10-09 | Common Stock (10000) | 10000 | Direct |
| Director Stock Option | $30.65 | 2012-10-24 | Common Stock (5000) | 5000 | Direct |
| Director Stock Option | $32.9 | 2013-10-23 | Common Stock (5000) | 5000 | Direct |
| Director Stock Option | $37.1 | 2014-10-21 | Common Stock (5000) | 5000 | Direct |
| Director Stock Option | $54.68 | 2015-10-26 | Common Stock (5000) | 5000 | Direct |
| Director Stock Option | $56.17 | 2016-10-25 | Common Stock (5000) | 5000 | Direct |
| Director Stock Option | $66.59 | 2017-10-24 | Common Stock (5000) | 5000 | Direct |
More from BIO-TECHNE Corp
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4
Regulatory Filings
2026
Feb 4